Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1ZIABC010442-24
Method Development: Efficient Computer Vision Based Algorithms
National Institutes of Health
Grant: 1ZIACP101231-06
Studies of Genetic and Environmental Epidemiology
National Health and Medical Research Council (NHMRC)
Grant: 1117663
Improving outcomes from melanoma
National Institutes of Health
Grant: 1ZIACP010144-16
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes
National Institutes of Health
Grant: 1ZIACP010201-02
Laboratory of Translational Genomics
Fields of Study
Keywords
Sustainable Development Goals